1、 王俊,金钧,黄坚,等.早期使用乌司他丁对中重症/重症急性胰腺炎患者疗效的影响[J]. 中华医学杂志,2017,97(16):1252-1255. 王俊,金钧,黄坚,等.早期使用乌司他丁对中重症/重症急性胰腺炎患者疗效的影响[J]. 中华医学杂志,2017,97(16):1252-1255.
2、 WANG Y J, LI L.Predicative values of C-reactive protein for the therapeutic effects of ulinastatin combined with somatostatin in severe acute pancreatitis and for the severity of gastrointestinal failure[J]. Exp Ther Med,2018,16(4):3165-3171. WANG Y J, LI L.Predicative values of C-reactive protein for the therapeutic effects of ulinastatin combined with somatostatin in severe acute pancreatitis and for the severity of gastrointestinal failure[J]. Exp Ther Med,2018,16(4):3165-3171.
3、 肖先水,苏晋簇,蒋佑成.低分子肝素、胰岛素联合治疗高脂血症性急性胰腺炎的疗效观察[J]. 中华胰腺病杂志,2017,17(4):265-267. 肖先水,苏晋簇,蒋佑成.低分子肝素、胰岛素联合治疗高脂血症性急性胰腺炎的疗效观察[J]. 中华胰腺病杂志,2017,17(4):265-267.
4、 吴光理,朱子宜.强化血糖控制对急性胰腺炎患者血糖波动及新发糖尿病的影响[J]. 浙江临床医学,2017,19(1):113-114. 吴光理,朱子宜.强化血糖控制对急性胰腺炎患者血糖波动及新发糖尿病的影响[J]. 浙江临床医学,2017,19(1):113-114.
5、 ALTINKAVA E, AKTAS A. Insulin and heparin therapies in acute pancreatitis due to hypertriglyceridemia[J]. J Coll Physicians Surg Pak, 2021,31(11):1337-1340. ALTINKAVA E, AKTAS A. Insulin and heparin therapies in acute pancreatitis due to hypertriglyceridemia[J]. J Coll Physicians Surg Pak, 2021,31(11):1337-1340.
6、 RAWLA P, SUNKARA T, THANDRA K C, et al. Hypertriglyceridemia-induced pancreatitis: updated review of current treatment and preventive strategies[J]. Clin J Gastroenterol,2018,11(6):441-448. RAWLA P, SUNKARA T, THANDRA K C, et al. Hypertriglyceridemia-induced pancreatitis: updated review of current treatment and preventive strategies[J]. Clin J Gastroenterol,2018,11(6):441-448.
7、 INAYAT F, ZAFAR F, RIAZ I, et al. Hypertriglyceridemic pancreatitis: is insulin monotherapy a feasible therapeutic option?[J] Cureus,2018,10(10):e3461. INAYAT F, ZAFAR F, RIAZ I, et al. Hypertriglyceridemic pancreatitis: is insulin monotherapy a feasible therapeutic option?[J] Cureus,2018,10(10):e3461.
8、 AYYAVOO A, RAGHUPATHY P, AGARWAL M, et al. Severe familial hypertriglyceridemia: successful treatment with insulin and a modified meal plan[J]. J Endocr Soc, 2018 ,2(12):1357-1362. AYYAVOO A, RAGHUPATHY P, AGARWAL M, et al. Severe familial hypertriglyceridemia: successful treatment with insulin and a modified meal plan[J]. J Endocr Soc, 2018 ,2(12):1357-1362.
9、 KUCHAY M S, FAROOQUI K J, BANO T, et al. Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review[J]. Arch Endocrinol Metab, 2017,61(2):198-201. KUCHAY M S, FAROOQUI K J, BANO T, et al. Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review[J]. Arch Endocrinol Metab, 2017,61(2):198-201.
10、 SONG X, SHI D, CUI Q, et al. Intensive insulin therapy versus plasmapheresis in the management of hypertriglyceridemia-induced acute pancreatitis (Bi-TPAI trial): study protocol for a randomized controlled trial[J]. Trials, 2019,20(1):365-365. SONG X, SHI D, CUI Q, et al. Intensive insulin therapy versus plasmapheresis in the management of hypertriglyceridemia-induced acute pancreatitis (Bi-TPAI trial): study protocol for a randomized controlled trial[J]. Trials, 2019,20(1):365-365.
11、 SAHU K K, MISHRA A K, LAL A, et al. Update on management of hypertriglyceridaemia-induced acute pancreatitis[J]. BMJ Case Rep, 2019, 12(8):e231703. SAHU K K, MISHRA A K, LAL A, et al. Update on management of hypertriglyceridaemia-induced acute pancreatitis[J]. BMJ Case Rep, 2019, 12(8):e231703.
12、 LUDES P O, de ROQUETAILLADE C, CHOUSTERMAN B G, et al. Role of damage-associated molecular patterns in septic acute kidney injury, from injury to recovery[J]. Front Immunol,2021, 1(12):606-622. LUDES P O, de ROQUETAILLADE C, CHOUSTERMAN B G, et al. Role of damage-associated molecular patterns in septic acute kidney injury, from injury to recovery[J]. Front Immunol,2021, 1(12):606-622.
13、 YAN Z, ZANG B, GONG X, et al. MiR-214-3p exacerbates kidney damages and inflammation induced by hyperlipidemic pancreatitis complicated with acute renal injury[J]. Life Sci,2020,15(241):117-118. YAN Z, ZANG B, GONG X, et al. MiR-214-3p exacerbates kidney damages and inflammation induced by hyperlipidemic pancreatitis complicated with acute renal injury[J]. Life Sci,2020,15(241):117-118.
14、 JIN M, BAI X, CHEN X, et al. A 16-year trend of etiology in acute pancreatitis: The increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis[J]. J Clin Lipidol, 2019,13(6):947-953. JIN M, BAI X, CHEN X, et al. A 16-year trend of etiology in acute pancreatitis: The increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis[J]. J Clin Lipidol, 2019,13(6):947-953.
15、 中国中西医结合学会普通外科专业委员会.重症急性胰腺炎中西医结合诊治指南(2014年,天津)[J]. 临床肝胆病杂志,2015,31(3):327-331. 中国中西医结合学会普通外科专业委员会.重症急性胰腺炎中西医结合诊治指南(2014年,天津)[J]. 临床肝胆病杂志,2015,31(3):327-331.
16、 中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编委会,《中华消化杂志》编委会.中国急性胰腺炎诊治指南(2019年,沈阳)[J]. 临床肝胆病杂志,2019,35(12):2706-2711. 中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编委会,《中华消化杂志》编委会.中国急性胰腺炎诊治指南(2019年,沈阳)[J]. 临床肝胆病杂志,2019,35(12):2706-2711.
17、 YANG A L, MCNABB-BALTAR J. Hypertriglyceridemia and acute pancreatitis[J]. Pancreatology,2020,20(5):795-800. YANG A L, MCNABB-BALTAR J. Hypertriglyceridemia and acute pancreatitis[J]. Pancreatology,2020,20(5):795-800.
18、 朱亮,祝荫,何文华, 等.江西省2 625例急性胰腺炎临床特征分析[J]. 中华消化杂志,2014,34(8):531-534. 朱亮,祝荫,何文华, 等.江西省2 625例急性胰腺炎临床特征分析[J]. 中华消化杂志,2014,34(8):531-534.
19、 CROCKETT S D, WANI S, GARDNER T B,et al. American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis[J]. Gastroenterology,2018,154(4):1096-1101. CROCKETT S D, WANI S, GARDNER T B,et al. American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis[J]. Gastroenterology,2018,154(4):1096-1101.
20、 LEE P J, PAPACHRISTOU G I. New insights into acute pancreatitis[J]. Nat Rev Gastroenterol Hepatol,2019,16(8):479-496. LEE P J, PAPACHRISTOU G I. New insights into acute pancreatitis[J]. Nat Rev Gastroenterol Hepatol,2019,16(8):479-496.
21、 SIREGAR G A, SIREGAR G P. Management of severe acute pancreatitis[J]. Open Access Maced J Med Sci,2019,7(19):3319-3323. SIREGAR G A, SIREGAR G P. Management of severe acute pancreatitis[J]. Open Access Maced J Med Sci,2019,7(19):3319-3323.
22、 GREENBERG J A, HSU J, BAWAZEER M, et al. Clinical practice guideline: management of acute pancreatitis[J]. Can J Surg,2016,59(2):128-140. GREENBERG J A, HSU J, BAWAZEER M, et al. Clinical practice guideline: management of acute pancreatitis[J]. Can J Surg,2016,59(2):128-140.